Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Harmonisation of CLL diagnosis and detection of residual disease monitoring by...

Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK

Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry ( Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK )

Results of subgroup analysis of the HELIOS trial

Dr Paula Cramer – University of Cologne, Cologne, Germany

Results of subgroup analysis of the HELIOS trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )

Primary results from the MABLE phase IIIb study

Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France

Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi...

Dr Amy Johnson – The Ohio State University, Columbus, USA

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )

Results of a new phase Ib trial of voxtalisib in combination with...

Prof Farrukh Awan - Ohio State University, Columbus, USA

Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )

A laboratory model of the hypoxic tumour microenvironment

Dr Giles Best - Royal North Shore Hospital, Sydney, Australia

A laboratory model of the hypoxic tumour microenvironment ( Dr Giles Best - Royal North Shore Hospital, Sydney, Australia )

New research into new small molecule IKKα inhibitors

Dr Elaine Willmore – University of Newcastle, Newcastle, UK

New research into new small molecule IKKα inhibitors ( Dr Elaine Willmore – University of Newcastle, Newcastle, UK )

Phase II study of idelalisib monotherapy in older CLL patients

Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA

Phase II study of idelalisib monotherapy in older CLL patients ( Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA )

History of the B-cell in its 50th anniversary year

Prof Max Cooper - Emory University, Atlanta, USA

History of the B-cell in its 50th anniversary year ( Prof Max Cooper - Emory University, Atlanta, USA )

Human B-cell receptor structure and function in CLL

Prof Freda Stevenson - University of Southampton, Southampton, UK

Human B-cell receptor structure and function in CLL ( Prof Freda Stevenson - University of Southampton, Southampton, UK )

Translational research and the future of CLL treatment

Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA

Translational research and the future of CLL treatment ( Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA )

The role of CLL cells, T-cells and macrophages and their effects on the tumour...

Prof Arnon Kater - Academic Medical Center, Amsterdam, The Netherlands

The role of CLL cells, T-cells and macrophages and their effects on the tumour microenvironment ( Prof Arnon Kater - Academic Medical Center, Amsterdam, The Netherlands )

More from ecancer